Researchers assessed whether a childhood asthma subgroup at high-risk for ARI could be identified using natural language processing algorithms as a “digital biomarker.” ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

New guidelines that seek to change how asthma is treated in Australia have been unveiled by Health Minister Mark Butler and ...

A joint scientific study conducted by researchers at the Medical Research Institute of New Zealand, in collaboration with ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

Natural language processing (NLP) algorithms can identify a subgroup of children with asthma who have a high risk for acute ...

Australia has overhauled the way asthma is treated, with doctors advised to stop prescribing blue “reliever” puffers alone ...

GPs have been advised to stop prescribing blue reliever inhalers alone for newly-diagnosed asthma. Instead, they should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to ...

The National Asthma Council’s advice for treating the condition has been updated, advising doctors against solely prescribing blue puffers to patients.

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...